Scott V. Becker

Orange County
  • 650 Town Center Drive
  • 20th Floor
  • Costa Mesa, CA 92626-1925
  • USA
 
 

Scott Becker is an associate in the Orange County office. His practice focuses on mergers and acquisitions, capital markets, and general corporate counseling.

Mr. Becker represents private and public companies, private equity firms, and financial institutions on a broad range of matters, including:

  • Mergers, acquisitions, and dispositions, including public company mergers and tender offers, and going private transactions
  • Private offerings of equity and equity-linked securities
  • Reorganizations, governance, and general corporate matters

Mr. Becker's representative transactions include the following matters:

Mergers and Acquisitions
  • A public biopharmaceutical company in its US$575 million merger of equals with another public biopharmaceutical company
  • A public medical device company in its US$30 sale to a strategic public acquiror
  • A public pet therapeutic company in its US$245 million sale to a public animal healthcare company
  • A public healthcare information company in its US$4.2 billion sale to a private equity firm
  • A public telecommunications company in its pending US$26.5 billion acquisition of a public competitor
  • A private medical transportation company in its US$742 million sale to a private equity firm
  • A public semiconductors and analog mixed-signal products company in its US$7.1 billion sale to a Japanese semiconductor manufacturer
  • A public specialized electronics manufacturer in its US$187 million acquisition of a public competitor
  • A public pharmaceutical company in its US$73 billion sale to another public pharmaceutical company
  • A private medical device company in its US$725 million sale to a public pharmaceutical company
  • A public healthcare information company in its US$4.8 billion sale to a private equity firm
  • A private medical device company in its US$662 million sale to a medical technologies firm
  • A public gaming company in its US$631 million sale to a public competitor
  • A private tactical apparel company in its US$400 million sale to a public investment firm
  • A private liquefied natural gas company in its US$68 million sale to a global chemicals company
Capital Markets
  • A public medical technologies company in a secondary offering of up to 2.5 million shares of common stock
  • A public real estate company in its US$200 million at-the-market offering program
  • A public REIT in its US$200 million public offering of common stock
  • A medical device company in its initial public offering and listing on the Nasdaq Global Market
  • The underwriters in multiple underwritten public offerings of US$8 billion of investment grade debt securities for a pharmaceutical company
  • A real estate investment trust in its initial formation and subsequent equity offerings
  • A medical device company in a US$60 million public offering of common stock
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.